The Missing Layer in Food as Medicine: Why Pharmacists Must Be at the Table

The Food as Medicine movement is garnering major attention. A 2026 panel of 58 health experts named it the second most important health trend of the year.¹ Blue Cross Blue Shield of North Carolina published data showing it reduces healthcare costs and improves chronic disease outcomes.² Hospitals are building programs around it. Dietitians are leading it. And patients—particularly patients from cultures where food has always been medicine—are embracing it with genuine enthusiasm.

But there is a layer missing from every Food as Medicine conversation I have encountered in 20 years of pharmacy practice. Food does not know what medication a patient is taking.

Grapefruit and grapefruit juice inhibit CYP3A4 and are contraindicated with over 85 commonly prescribed medications, including statins, calcium channel blockers, and immunosuppressants.³ Vitamin K-rich leafy greens directly antagonize warfarin anticoagulation.⁴ High-dose turmeric inhibits CYP2C9 and raises international normalized ratio in patients on warfarin.⁵ Moringa, widely consumed in West African and Caribbean communities, has documented hypoglycemic activity that produces additive effects in patients on sulfonylureas and GLP-1 receptor agonists.⁶ Fenugreek and bitter melon—staples of South Asian cooking—produce clinically significant blood sugar reductions that interact with diabetes medications in ways that are rarely communicated during clinical encounters.^7,8

These are not rare edge cases. They are daily realities for the patients who stand to benefit most from Food as Medicine programs: older adults with polypharmacy, patients from culturally diverse communities, and patients managing multiple chronic conditions simultaneously. These are precisely the patients for whom food-medication interactions are most clinically significant and most systematically overlooked.

The gap is not the food. The gap is the medication layer.

As pharmacists, we are the only clinicians trained to see both sides of this equation. We understand the pharmacokinetics of the interaction and the cultural context of the diet. We are the most accessible health care providers in the United States, with more patient contact points than any physician specialty. And we are almost entirely absent from the Food as Medicine conversation.

This needs to change. Food as Medicine programs that do not include pharmacist-led food-drug interaction screening are clinically incomplete. They may be doing harm they cannot see. I am writing because the field is moving fast, and the medication layer cannot be left behind.

Pharmacists belong at the Food as Medicine table. Not to restrict, but to complete the clinical picture.

About the Author
Oluremi Olukoya, PharmD, is a clinical pharmacist and the founder of MediMeal Safe, a digital health platform that provides personalized, culturally adapted food-drug interaction guidance for patients and the clinicians who serve them.

REFERENCES

1. Urban A. Top health and nutrition trends for 2026. US News & World Report. January 5, 2026. Accessed July 21, 2026. https://health.usnews.com/wellness/articles/top-health-and-nutrition-trends-for-2026

2. New data shows Blue Cross NC’s Feed Your Health program reduces health care costs, improves chronic disease management. News release. Blue Cross Blue Shield of North Carolina. April 29, 2026. Accessed July 21, 2026. https://mediacenter.bcbsnc.com/news/feedyourhealthresults

3. Lee JW, Morris JK, Wald NJ. Grapefruit juice and statins. Am J Med. 2016;129(1):26-29. doi:10.1016/j.amjmed.2015.07.036

4. Violi F, Lip GYH, Pignatelli P, Pastori D. Interaction between dietary vitamin K intake and anticoagulation by vitamin K antagonists: is it really true? Medicine (Baltimore). 2016;95(10):e2895. doi:10.1097/MD.0000000000002895

5. Rusdiana T, Mardhiani YD, Putriana NA, et al. The influence of Javanese turmeric (Curcuma xanthorrhiza) on the pharmacokinetics of warfarin in rats with single and multiple-dose studies. Pharm Biol. 2021;59(1):637-644. doi:10.1080/13880209.2021.1928716

6. Moringa. Drugs.com. Updated February 19, 2026. Accessed July 21, 2026. https://www.drugs.com/npp/moringa.html

7. Shabil M, Bushi G, Bodige PK, et al. Effect of fenugreek on hyperglycemia: a systematic review and meta-analysis. Medicine (Kaunas). 2023;59(2):248. doi:10.3390/medicina59020248

8. Efird JT, Choi YM, Davies SW, Mehra S, Anderson EJ, Katunga LA. Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes. Int J Environ Res Public Health. 2014;11(2):2328-2345. doi:10.3390/ijerph110202328